Pharmaceutical composition for preventing and treating schizophrenia

A technology for schizophrenia and composition, which is applied in the directions of drug combination, medical preparations containing active ingredients, and pharmaceutical formulations, etc., can solve the problems of difficult to reach patients, long course of treatment, no dosage form and dosage, etc.

CN105582049AInactive Publication Date: 2016-05-18JINAN XINGYI MEDICAL TECH
0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
Publication Date
2016-05-18
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
Patent Text Reader

Abstract

The invention discloses pharmaceutical composition for preventing and treating schizophrenia and a preparation method of the pharmaceutical composition. The pharmaceutical composition is prepared from Rallidae, radix et rhizoma thermopsis, bilobetin, herba saussureae brunneopilosae and Centaurium pulchellum as raw medical materials through matching. The pharmaceutical composition can be prepared in various forms according to a conventional preparation process and has remarkable curative effects on schizophrenia prevention and treatment.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the technical field of traditional Chinese medicines, and in particular relates to a pharmaceutical composition for preventing and treating schizophrenia and a preparation method thereof. Background technique

[0002] Schizophrenia is a common mental illness. Most of the onsets are in young adults, manifested as functional impairments in perception, emotion, volitional behavior, and thinking. Mental activities are not coordinated with the surrounding environment and inner experience, and are divorced from reality. General unconsciousness disorder and obvious mental retardation may have cognitive function impairment in attention, working memory, abstract thinking and information integration. The course of the disease is often protracted and recurrent, and some patients suffer from mental activity decline and varying degrees of social function impairment. According to the estimation of the World Health Organization, the lifetim...

Examples

Embodiment 1

[0035] Embodiment 1: the pharmaceutical composition for preventing and treating schizophrenia and its preparation method

[0036] The composition and parts by weight of the raw material drug of the pharmaceutical composition for preventing and treating schizophrenia are: 7730g of crakes, 6700g of Zihua Huanghua, 360g of gingkoxanthin, 4430g of 4430g, 500g of Elephantia chinensis;

[0037] Preparation:

[0038] (1) According to the ratio of raw materials, take rail, purple flower yellow flower, ginkgo xanthin, chrysanthemum chrysanthemum, and asteroides, mix them evenly, use ethanol with a concentration of 19.5% by weight as a solvent, and extract by warm soaking at 27.5°C. 24 times, each extraction time is 1.4 hours, each solvent consumption is 31.5 times of the total weight of the crude drug, filtered to obtain medicinal residue A and extract A, extract A reclaims ethanol, concentrates to a relative density of 1.16, and filters After that, the medicinal solution passes throu...

Embodiment 2

[0041] Embodiment 2: the pharmaceutical composition for preventing and treating schizophrenia and its preparation method

[0042] The composition and parts by weight of the raw material drug of the pharmaceutical composition for preventing and treating schizophrenia are: 7700g of crake, 6800g of Zihuahuanghua, 350g of gingkoxanthin, 4440g of 4440g, 400g of Erythrina fruticosa;

[0043] Preparation:

[0044] (1) According to the ratio of raw materials, take rail, purple flower yellow flower, ginkgo xanthin, chrysanthemum chrysanthemum, and asteroides, mix them evenly, use ethanol with a concentration of 19.5% by weight as a solvent, and extract by warm soaking at 27.5°C. 24 times, each extraction time is 1.4 hours, each solvent consumption is 31.5 times of the total weight of the crude drug, filtered to obtain medicinal residue A and extract A, extract A reclaims ethanol, concentrates to a relative density of 1.16, and filters After that, the medicinal solution passes through ...

Embodiment 3

[0047] Embodiment 3: the pharmaceutical composition for preventing and treating schizophrenia and its preparation method

[0048] The composition and parts by weight of the raw material drug of the pharmaceutical composition for preventing and treating schizophrenia are: 7760g of crake, 6600g of Zihua Huanghua, 370g of gingkoxanthin, 4420g of 4420g, and 600g of geranium;

[0049] Preparation:

[0050] (1) According to the ratio of raw materials, take rail, purple flower yellow flower, ginkgo xanthin, chrysanthemum chrysanthemum, and asteroides, mix them evenly, use ethanol with a concentration of 19.5% by weight as a solvent, and extract by warm soaking at 27.5°C. 24 times, each extraction time is 1.4 hours, each solvent consumption is 31.5 times of the total weight of the crude drug, filtered to obtain medicinal residue A and extract A, extract A reclaims ethanol, concentrates to a relative density of 1.16, and filters After that, the medicinal solution passes through the D3...